| Literature DB >> 34434606 |
Ahmed Halfadji1,2,3, Mohamed Naous1,4, Farida Bettiche5, Abdelkrim Touabet3.
Abstract
BACKGROUND: Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental organic contaminants generated by incomplete combustion of organic materials that are widely distributed in soils.Entities:
Keywords: Algerian public health; ILCR; PAHs; health risk assessment; incremental lifetime cancer risk; polycyclic aromatic hydrocarbons; soil pollution; total cancer risk
Year: 2021 PMID: 34434606 PMCID: PMC8383786 DOI: 10.5696/2156-9614-11.31.210914
Source DB: PubMed Journal: J Health Pollut ISSN: 2156-9614
Benzo[a]pyrene Toxic Equivalency (BaPeq) and Concentrations of 16 PAHs (μg/kg) Detected in Soil Samples of the Study Area
| Levels of 16 PAHs in sampling sites | Levels of 16 PAHs in surface soils of study area (μg/kg) (2018) | Levels of 16 PAHs in surface soils of study area (μg/kg] | BaPeq (μg Teq/kg) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAH | A | TEF |
|
|
|
|
|
|
|
|
|
|
|
|
| Naphthalene | 2 | 0.001 | 36.16 | 19.90 | 64.18 | 0.16 | 0.04 | 0.36 | 18.16 | 0.04 | 64.18 | 0.02 | 4.18 × 10−5 | 0.06 |
| Acenaphthylene | 3 | 0.001 | 17.06 | 3.94 | 32.63 | 33.93 | 0.02 | 133.37 | 25.50 | 0.02 | 133.37 | 0.03 | 1.93 × 10−5 | 0.13 |
| Acenaphthene | 3 | 0.001 | 9.38 | 4.14 | 16.32 | 0.84 | 0.02 | 2.25 | 5.11 | 0.02 | 16.32 | 0.01 | 1.91 × 10−5 | 0.02 |
| Fluorene | 3 | 0.001 | 8.45 | 4.13 | 13.56 | 1.80 | 0.75 | 3.63 | 5.13 | 0.75 | 13.56 | 0.01 | 7.51 × 10−4 | 0.01 |
| Phenanthrene | 3 | 0.001 | 57.43 | 19.25 | 110.49 | 131.64 | 36.73 | 399.09 | 94.53 | 19.25 | 399.09 | 0.09 | 0.02 | 0.40 |
| Anthracene | 3 | 0.01 | 12.05 | 2.88 | 24.21 | 65.88 | 1.49 | 251.37 | 38.97 | 1.49 | 251.37 | 0.39 | 0.01 | 2.51 |
| Fluoranthene | 4 | 0.001 | 90.49 | 19.37 | 176.49 | 687.18 | 33.03 | 2513.46 | 388.84 | 19.37 | 2513.46 | 0.39 | 0.02 | 2.51 |
| Pyrene | 4 | 0.001 | 80.49 | 16.47 | 158.75 | 697.50 | 132.56 | 2342.65 | 388.99 | 16.47 | 2342.65 | 0.39 | 0.02 | 2.34 |
| Benzo[a] anthracene | 4 | 0.1 | 52.71 | 8.98 | 90.11 | 515.09 | 5.11 | 1920.02 | 283.90 | 5.11 | 1920.02 | 28.39 | 0.51 | 192.00 |
| Chrysene | 4 | 0.01 | 23.71 | 7.60 | 42.31 | 137.70 | 4.43 | 482.93 | 80.71 | 4.43 | 482.93 | 0.81 | 0.04 | 4.83 |
| Benzo[b] fluoranthene | 5 | 0.1 | 124.92 | 21.59 | 191.02 | 198.22 | 3.22 | 720.57 | 161.57 | 3.22 | 720.57 | 16.16 | 0.32 | 72.06 |
| Benzo[k] fluoranthene | 5 | 0.1 | 55.29 | 10.12 | 88.86 | 116.98 | 1.86 | 421.56 | 86.14 | 1.86 | 421.56 | 8.61 | 0.19 | 42.16 |
| Benzo[a]pyrene (BaP] | 5 | 1 | 76.39 | 16.35 | 121.23 | 140.09 | 2.19 | 506.48 | 108.24 | 2.19 | 506.48 | 108.24 | 2.19 | 506.48 |
| Indeno(1,2,3-c,d)pyrene | 6 | 0.01 | 77.86 | 8.51 | 133.27 | 97.84 | 2.83 | 345.67 | 87.85 | 2.83 | 345.67 | 0.88 | 0.03 | 3.46 |
| Dibenzo(a,h)anthracene | 5 | 5 | 19.95 | 2.81 | 34.97 | 23.04 | 1.20 | 81.33 | 21.50 | 1.20 | 81.33 | 107.48 | 10.20 | 181.33 |
| Benzo (g,h,i]perylene | 6 | 0.1 | 87.25 | 14.73 | 140.74 | 80.74 | 2.55 | 280.34 | 84.00 | 2.55 | 280.34 | 8.40 | 0.26 | 28.03 |
| Σ16 PAHs | 829.6 | 180.8 | 1350.3 | 2928.6 | 239.8 | 10404.8 | 1879.11 | 180.77 | 10404.81 | |||||
| BaPeqΣ7PAHsCarcin | 270.57 (96.5%) | 13.48 | 1002.32 | |||||||||||
| TEQ | 280.28 | 14.81 | 1038.35 | |||||||||||
Abbreviations: A, number of aromatic rings; TEF, toxic equivalency factor; TEQ, toxic equivalency quotient
*16 PAHs reported in previously study, Halfadji et al.20
** 16 PAHs from 20 PAHs reported in study area, Djellouli et al.19
Exposure Variables for the Health Risk Assessment for Children, Adolescents and Adults via Ingestion, Inhalation and Dermal Exposure Pathways
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Average body weight | Kg | 24.2 | 56.8 | 69.6 |
|
| Unit conversion factor | Kg/mg | 1.00×106 | 1.00×106 | 1.00×106 | |
| Exposure frequency | Days/years | 350 | 350 | 350 |
|
| Exposure duration | Years | 7 | 10 | 41 |
|
| Inhalation rate | m3/day | 10 | 16 | 16 | |
| Soil ingestion rate | mg/day | 200 | 100 | 100 |
|
| Dermal surface exposure | cm2/day | 2800 | 5700 | 5700 |
|
| Dermal adherence factor | mg /cm2 | 0.2 | 0.2 | 0.07 |
|
| Dermal adsorption fraction | Unitless | 0,13 | 0,13 | 0,13 |
|
| Lifetime | Years | 72 | 72 | 72 |
|
| Average life span | Days | 26 280 | 26 280 | 26 280 |
|
| Particulate emission factor | m3/kg | 1.36×109 | 1.36×109 | 1.36×109 |
|
| Cancer slope factor ingestion | mg/kg/day | 7.3 | 7.3 | 7.3 |
|
| Cancer slope factor dermal | mg/kg/day | 25 | 25 | 25 |
|
| Cancer slope factor inhalation | mg/kg/day | 3.85 | 3.85 | 3.85 |
|
Incremental Lifetime Cancer Risk (ILRC) for Human Exposure to Individual Polyaromatic Hydrocarbons (PAHs) via Dermal Contact Exposure to Surface Soils in the Study Area
|
|
| ||
|---|---|---|---|
|
| |||
|
|
|
| |
| Naphthalene | 1.33 × 10−7 | 1.65 × 10−7 | 1.93 × 10−7 |
| Acenaphthylene | 1.86 × 10−7 | 2.31 × 10−7 | 2.70 × 10−7 |
| Acenaphthene | 3.74 × 10−8 | 4.63 × 10−8 | 5.42 × 10−8 |
| Fluorene | 3.75 × 10−8 | 4.64 × 10−8 | 5.44 × 10−8 |
| Phenanthrene | 6.91 × 10−7 | 8.56 × 10−7 | 1.00 × 10−6 |
| Anthracene | 2.85 × 10−7 | 3.53 × 10−7 | 4.13 × 10−7 |
| Fluoranthene | 2.84 × 10−6 | 3.52 × 10−6 | 4.13 × 10−6 |
| Pyrene | 2.84 × 10−6 | 3.52 × 10−6 | 4.13 × 10−6 |
| Benzo[a]anthracene | 2.08 × 10−6 | 2.57 × 10−6 | 3.01 × 10−6 |
| Chrysene | 5.90 × 10−7 | 7.31 × 10−7 | 8.56 × 10−7 |
| Benzo[b ]fluoranthene | 1.18 × 10−6 | 1.46 × 10−6 | 1.71 × 10−6 |
| Benzo[k]fluoranthene | 6.30 × 10−7 | 7.80 × 10−7 | 9.14 × 10−7 |
| Benzo[a]pyrene (BaP) | 7.91 × 10−7 | 9.81 × 10−7 | 1.15 × 10−6 |
| Indeno(1,2,3-c,d)pyrene | 6.42 × 10−7 | 7.96 × 10−7 | 9.32 × 10−7 |
| Dibenzo(a,h)anthracene | 1.57 × 10−7 | 1.95 × 10−7 | 2.28 × 10−7 |
| Benzo(g,h,i)perylene | 6.14 × 10−7 | 7.61 × 10−7 | 8.91 × 10−7 |
| Σ2–3-ring | 1.37 × 10−6 | 1.70 × 10−6 | 1.99 × 10−6 |
| Σ4ring | 8.35 × 10−6 | 1.04 × 10−5 | 1.21 × 10−5 |
| Σ5ring | 2.76 × 10−6 | 3.42 × 10−6 | 4.00 × 10−6 |
| Σ6ring | 1.26 × 10−6 | 1.56 × 10−6 | 1.82 × 10−6 |
|
|
|
|
|
Incremental Lifetime Cancer Risk (ILRC) for Human Exposure to Individual Polyaromatic Hydrocarbons (PAHs) via Inhalation Exposure to Surface Soils in the Study
|
|
| ||
|---|---|---|---|
|
| |||
|
|
|
| |
| Naphthalene | 2.07 × 10−12 | 2.01 × 10−12 | 6.73 × 10−12 |
| Acenaphthylene | 2.90 × 10−12 | 2.82 × 10−12 | 9.45 × 10−12 |
| Acenaphthene | 5.81 × 10−13 | 5.66 × 10−13 | 1.89 × 10−12 |
| Fluorene | 5.83 × 10−13 | 5.68 × 10−13 | 1.90 × 10−12 |
| Phenanthrene | 1.08 × 10−11 | 1.05 × 10−11 | 3.50 × 10−11 |
| Anthracene | 4.43 × 10−12 | 4.32 × 10−12 | 1.44 × 10−11 |
| Fluoranthene | 4.42 × 10−11 | 4.31 × 10−11 | 1.44 × 10−10 |
| Pyrene | 4.42 × 10−11 | 4.31 × 10−11 | 1.44 × 10−10 |
| Benzo[a]anthracene | 3.23 × 10−11 | 3.14 × 10−11 | 1.05 × 10−10 |
| Chrysene | 9.18 × 10−12 | 8.94 × 10−12 | 2.99 × 10−11 |
| Benzo[b]fluoranthene | 1.84 × 10−11 | 1.79 × 10−11 | 5.99 × 10−11 |
| Benzo[k]fluoranthene | 9.80 × 10−12 | 9.54 × 10−12 | 3.19 × 10−11 |
| Benzo[a]pyrene (BaP) | 1.23 × 10−11 | 1.20 × 10−11 | 4.01 × 10−11 |
| Indeno(1,2,3-c,d)pyrene | 9.99 × 10−12 | 9.73 × 10−12 | 3.26 × 10−11 |
| Dibenzo(a,h)anthracene | 2.44 × 10−12 | 2.38 × 10−12 | 7.97 × 10−12 |
| Benzo(g,h,i)perylene | 9.55 × 10−12 | 9.30 × 10−12 | 3.11 × 10−11 |
| Σ2–3-ring | 2.13 × 10−11 | 2.08 × 10−u | 6.94 × 10−11 |
| Σ4ring | 1.30 × 10−10 | 1.27 × 10−10 | 4.23 × 10−10 |
| Σ5ring | 4.29 × 10−11 | 4.18 × 10−11 | 1.40 × 10−10 |
| Σ6ring | 1.95 × 10−11 | 1.90 × 10−11 | 6.37 × 10−11 |
| Σ |
|
|
|
Cancer Risk and Corresponding Incremental Lifetime Cancer Risk Across Age Groups via Different Exposure Routes to Contaminated Soil
|
| ||||
|---|---|---|---|---|
| Exposure pathway | ILCR ingestion | ILCR inhalation | ILCR dermal | Cancer risk (R) |
| Min | 4.74 × 10−7 | 9.19 × 10−12 | 5.91 × 10−7 | 1.06 × 10−6 |
| Max | 6.15 × 10−5 | 1.19 × 10−9 | 7.67 × 10−5 | 1.38 × 10−4 |
| Mean |
|
|
|
|
|
| ||||
| Exposure pathway | ILCR ingestion | ILCR inhalation | ILCR dermal | R |
| Min | 1.44 × 10−7 | 8.95 × 1012 | 7.32 × 10−7 | 8.76 × 10−7 |
| Max | 1.87 × 10−5 | 1.16 × 10−9 | 9.51 × 10−5 | 1.14 × 10−4 |
| Mean |
|
|
|
|
|
| ||||
| Exposure pathway | ILCR ingestion | ILCR inhalation | ILCR dermal | R |
| Min | 4.83 × 10−7 | 2.99 × 10−11 | 8.57 × 10−7 | 1.34 × 10−6 |
| Max | 6.27 × 10−5 | 3.89 × 10−9 | 1.11 × 10−4 | 1.74 × 10−4 |
|
|
|
|
|
|
Incremental Lifetime Cancer Risk (ILRC) for Human Exposure to Individual Polyaromatic Hydrocarbons (PAHs) via Ingestion to Surface Soils in the Study Area
|
|
| ||
|---|---|---|---|
|
| |||
|
|
|
| |
| Naphthalene | 1.07 × 10−7 | 3.24 × 10−8 | 1.08 × 10−7 |
| Acenaphthylene | 1.50 × 10−7 | 4.55 × 10−8 | 1.52 × 10−7 |
| Acenaphthene | 3.00 × 10−8 | 9.12 × 10−9 | 3.05 × 10−8 |
| Fluorene | 3.01 × 10−8 | 9.15 × 10−9 | 3.06 × 10−8 |
| Phenanthrene | 5.54 × 10−7 | 1.69 × 10−7 | 5.65 × 10−7 |
| Anthracene | 2.29 × 10−7 | 6.96 × 10−8 | 2.33 × 10−7 |
| Fluoranthene | 2,28 × 10−6 | 6.94 × 10−7 | 2.32 × 10−6 |
| Pyrene | 2,28 × 10−6 | 6.94 × 10−7 | 2.32 × 10−6 |
| Benzo[a]anthracene | 1.67 × 10−6 | 5.07 × 10−7 | 1.70 × 10−6 |
| Chrysene | 4.73 × 10−7 | 1.44 × 10−7 | 4.82 × 10−7 |
| Benzo[b]fluoranthene | 9.48 × 10−7 | 2.88 × 10−7 | 9.65 × 10−7 |
| Benzo[k]fluoranthene | 5.05 × 10−7 | 1.54 × 10−7 | 5.14 × 10−7 |
| Benzo[a]pyrene (BaP) | 6.35 × 10−7 | 1.93 × 10−7 | 6.46 × 10−7 |
| Indeno(1,2,3-c,d)pyrene | 5.15 × 10 7 | 1.57 × 10−7 | 5.25 × 10−7 |
| Dibenzo(a,h)anthracene | 1.26 × 10−7 | 3.84 × 10−8 | 1.28 × 10−7 |
| Benzo(g,h,i)perylene | 4.93 × 10−7 | 1.50 × 10−7 | 5.02 × 10−7 |
| Σ2–3-ring | 1.10 × 10−6 | 3.34 × 10−7 | 1.12 × 10−6 |
| Σ4ring | 6.70 × 10−6 | 2.04 × 10−6 | 6.82 × 10−6 |
| Σ5ring | 2.21 × 10−6 | 6.74 × 10−7 | 2.25 × 10−6 |
| Σ6ring | 1.01 × 10−6 | 3.07 × 10−7 | 1.03 × 10−6 |
|
|
|
|
|